You are here

breast cancer

Boehringer Ingelheim Initiates Phase III Clinical Trial With Afatinib in Advanced Breast Cancer

PR-USA

Sat, 12/11/10 - 12:57 pm

Boehringer Ingelheim

Drug combo helps women with early breast cancer

Yahoo/AP

Sat, 12/11/10 - 12:00 pm

Something Is Better Than Nothing, I Guess (Novartis, Zometa)

Motley Fool

Sat, 12/11/10 - 11:50 am

ImmunoGen, Inc. Announces Clinical Data for T-DM1 Used in Combination with Pertuzumab for First-Line Treatment of HER2+ Metastatic Breast Cancer

Yahoo/BusinessWire

Sat, 12/11/10 - 11:48 am

Amgen Presents New XGEVA (Denosumab) Breast Cancer Skeletal-Related Event Prevention Data at SABCS

Yahoo/PR NewsWire

Sat, 12/11/10 - 11:41 am

Novartis's Failure With Zometa in Breast Cancer Stalls $1 Billion Booster

Bloomberg

Fri, 12/10/10 - 10:15 am

Study: Herceptin plus Tykerb helps women with early breast cancer more than either drug alone

Yahoo/AP

Fri, 12/10/10 - 10:04 am

Roche/Genentech

Novartis to Withdraw Expanded Zometa Approval Request After Trial Failure

Bloomberg

Thu, 12/9/10 - 01:21 pm

Hologic gets FDA approvable letter for 3D mammography

Tue, 11/23/10 - 09:54 am

Aeterna Zentaris Presents Encouraging Preclinical Data On Two Novel Orally Active Anti-Cancer Compounds At Major Conference In Germany

Medical News Today

Sat, 11/20/10 - 01:17 pm

Aeterna Zentaris

prostate cancer

endometrial cancer

Eisai Plans Sale of Cancer Medicine in the U.S. as Aricept Protection Ends

Bloomberg

Tue, 11/16/10 - 11:57 am

Eisai Wins U.S. Approval to Sell Drug Injected for Advanced Breast Cancer

Bloomberg

Mon, 11/15/10 - 06:26 pm

IsoRay Awarded More Than $526,000 in Federal Grants for Breast, Brain and Lung Cancer

Mon, 11/8/10 - 07:49 am

internal radiation therapy

Pfizer Bone Drug Reduces Breast Cancer Risk in Older Women

Bloomberg

Thu, 11/4/10 - 09:59 pm

The Feds Come Out Against Gene Patents. It’s About Time.

Forbes

Mon, 11/1/10 - 10:05 am

Myriad Genetics

Myriad joins Abbott Labs' breast cancer study

Yahoo/AP

Wed, 10/27/10 - 11:41 am

Abbott Laboratories

Successful IsoRay Study of Cesium-131 Internal Radiation Therapy for Breast Cancer Paves the Way for Advanced Treatment

Wed, 10/27/10 - 10:22 am

internal radiation therapy

Pfizer Hormones Almost Double Breast-Cancer Death Risk, U.S. Study Shows

Bloomberg

Wed, 10/20/10 - 09:35 am

NICE to compare Tyverb, Herceptin in breast cancer

Fierce Pharma

Thu, 10/14/10 - 11:16 am

Merck KGaA’s Erbitux Delays Progression of Breast Cancer in Test

Bloomberg

Mon, 10/11/10 - 10:48 am

Pages